Chemed Corp (NYSE:CHE)
$ 575.24 1.11 (0.19%) Market Cap: 8.68 Bil Enterprise Value: 8.51 Bil PE Ratio: 30.96 PB Ratio: 7.33 GF Score: 96/100

Chemed Corp at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 16, 2022 / 12:40PM GMT
Release Date Price: $483.01 (+1.20%)
Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

Good morning, and welcome to Day 2 of Oppenheimer's 32nd Annual Healthcare Conference. My name is Michael Wiederhorn. I'm the health care services analyst here. Today, we're hosting Chemed. We have President and CEO, Kevin McNamara; Chief Financial Officer, David Williams; President and CEO of VITAS, Nick Westfall. So today is going to be a fireside chat format for the audience. We should -- there should be a Q&A portal on the top right corner of your screen to submit questions, and feel free to use that function.

Questions & Answers

Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst

So good morning, guys. Thanks for coming. Thanks. And hopefully, this will be our last virtual hopefully, next year, we'll be back in person. Welcome. So I'll just kind of jump right into it here with kind of a broad question. Just kind of can you update us what you're seeing in terms of emissions and expenses trends post on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot